We provide unwavering support in crafting medical evidence to the MAH narrative. From the early stages of development to commercialization, leverage our extensive Medical Affairs capabilities to drive your narrative, ensuring informed healthcare decision-making and improved patient outcomes. Our seamlessly integrated team stands ready to communicate the safety, effectiveness, and impactful outcomes of your product, ensuring a comprehensive and compelling presence throughout its lifecycle.
Team PharmXL has a decade long track record of supporting the life sciences industry with narrative writing services. Our content delivery model involves optimizing technology to create and deliver content aimed at creating the desired impact with the respective audience.
We assist you in formulating and conducting your Post Approval studies, adhering to the territory regulatory guidelines. Our commitment is to provide support in both the design and execution of studies. Our methodological and statistical expertise, results in creative solutions to best serve clients to:
identify, characterize or quantify a safety hazard;
confirm the safety profile of a medicine, or;
measure the effectiveness of risk-management measures.
Elevate your scientific narrative with our specialized Medical and Scientific Communication Services. We offer tailored solutions to life sciences industries, ensuring precise and impactful communication with health authorities, health care professionals and consumers. Partner with us to enhance your engagement with stakeholders, from research and development to commercialization, for a compelling and influential presence in the industry. Our experienced specialists craft custom content optimized for multi-channel delivery including:
Scientific communications platforms
Peer-reviewed publication with digital pull-through
Complete KOL identification and engagement plans
At our global team, we are dedicated to strategic planning and seamless execution, harnessing cross-functional expertise to deliver customized solutions that empower organizational transformation. We specialize in strategic engagements for assets, portfolios, and therapeutic areas, with a primary focus on enhancing the perception of clinical, economic, and patient value.
We empower you to navigate the complex journey from research to market success by providing robust health economic modelling solutions and help in overcoming regulatory challenges with market-specific evidence tailored by team, comprising medical, pharmaceutical and multi-dimensional experts, delivering scientifically rigorous and commercially relevant solutions.
- Our HEOR team assists you in defining product value through an array of
Portfolio planning
Economic and outcomes literature reviews
Burden/cost of illness studies
Treatment pattern analyses
Trial/market simulation modeling
Oversight of economic endpoints in clinical trials
Patient Reported Outcome (PRO) studies:
Creation of global and country-specific value dossiers
Comprehensive pricing and market access research
We specialize in collaborating with you to deliver tailored stand-alone and integrated safety and pharmacovigilance services across the entire life cycle of your medicinal products or services. Full pharmacovigilance services include safety call center services for:
Adverse Events
Product complaints
Medical Information Handling